Xu Zhu

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies.

Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: From Targeted Therapy and Combination Strategies to Emerging Therapies.

Journal: Biomedicines

Published: May 30, 2026

Biliary drainage plus hepatic arterial infusion chemotherapy versus biliary drainage plus best supportive care for advanced perihilar cholangiocarcinoma in China: a prospective multicentre non-randomised controlled study.

Biliary drainage plus hepatic arterial infusion chemotherapy versus biliary drainage plus best supportive care for advanced perihilar cholangiocarcinoma in China: a prospective multicentre non-randomised controlled study.

Journal: EClinicalMedicine

Published: February 02, 2026

Efficacy and safety of drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in unresectable gastric cancer with liver metastasis.

Efficacy and safety of drug-eluting bead transarterial chemoembolization combined with hepatic arterial infusion chemotherapy in unresectable gastric cancer with liver metastasis.

Journal: Therapeutic advances in medical oncology

Published: December 15, 2025

Application of microfluidic chip coupled with carbon dots-MOF-enriched chromogenic membrane in the detection of various perfluorinated compounds.

Application of microfluidic chip coupled with carbon dots-MOF-enriched chromogenic membrane in the detection of various perfluorinated compounds.

Journal: Journal of hazardous materials

Published: September 10, 2025

Combining partial splenic embolization with hepatic artery infusion chemotherapy in the management of chemotherapy-induced hypersplenism in patients with colorectal cancer liver metastases.

Combining partial splenic embolization with hepatic artery infusion chemotherapy in the management of chemotherapy-induced hypersplenism in patients with colorectal cancer liver metastases.

Journal: Journal of cancer research and therapeutics

Published: April 03, 2025

Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.

Phase 2 study of serplulimab with the bevacizumab biosimilar HLX04 in the first-line treatment of advanced hepatocellular carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: October 12, 2024

A machine learning-based prognostic stratification of locoregional interventional therapies for patients with colorectal cancer liver metastases: a real-world study.

A machine learning-based prognostic stratification of locoregional interventional therapies for patients with colorectal cancer liver metastases: a real-world study.

Journal: Therapeutic advances in medical oncology

Published: September 28, 2024

Chinese expert consensus: Radioactive iodine-125 seed interstitial brachytherapy for retroperitoneal lymph node metastases (2024 edition).

Chinese expert consensus: Radioactive iodine-125 seed interstitial brachytherapy for retroperitoneal lymph node metastases (2024 edition).

Journal: Journal of cancer research and therapeutics

Published: September 06, 2024

Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis.

Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis.

Journal: Hepatobiliary surgery and nutrition

Published: August 22, 2024

Efficacy and safety of hepatic arterial infusion chemotherapy combined with fruquintinib and tislelizumab for patients with microsatellite stable colorectal cancer liver metastasis following failure of multiple-line therapy.

Efficacy and safety of hepatic arterial infusion chemotherapy combined with fruquintinib and tislelizumab for patients with microsatellite stable colorectal cancer liver metastasis following failure of multiple-line therapy.

Journal: Frontiers in oncology

Published: April 21, 2024

Construction of an Injectable Composite Double-Network Hydrogel as a Liquid Embolic Agent.

Construction of an Injectable Composite Double-Network Hydrogel as a Liquid Embolic Agent.

Journal: Biomacromolecules

Published: March 01, 2024

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.

Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆.

Journal: JHEP reports : innovation in hepatology

Published: December 15, 2023

Showing 1-12 of 68

Last Updated: 09/26/2026